ABOUT CURE FIRST

REGISTERED 501(C)(3) NONPROFIT ORGANIZATION

Cure First was founded with the mission to support innovation in cancer research by adopting of novel technologies incluiding functional genomics to accelerate discoveries of safer and targeted cancer medicines. Until now our work has been in the research setting for ovarian and breast cancers and neuroblastoma. It has led to important publications that indicate new drug regimens for patients whose cancers show specific mutations or for patients with certain genetic predispositions.

Thank you for your past support of this groundbreaking research!

During its quest to identify novel therapeutic approaches, Cure First was confronted by a major obstacle: Most cancer-targeted drugs that the research findings indicated are only approved for certain cancer types and thus difficult to obtain for Drs, in treating other cancers because of the lack of insurance reimbursement. Cure First also realized the challenges and importance of communicating up-to-date findings and information that is typically handled by doctors and scientists to the most important target audience: the patients themselves.

Cure First is now looking to redirect its MISSION to help cancer patients obtain and understand the latest tests and therapies that can guide their personalized treatments.

Our efforts will empower patients to make informed decisions that can improve outcome and wellbeing.

We will further outline our strategy for Cure First’s new direction in the coming months. Please visit here again soon. If you would like to support Cure First ongoing efforts, we are still accepting your kind donations.